A method for processing electrocardiograph (ECG) data using a garment includes determining, by a processor, a current working lead from ECG leads formed in advance using flexible electrodes in the garment based on a current ECG monitor type, and receiving, by the processor through lead wires corresponding to the current working lead, ECG data collected by flexible electrodes corresponding to the current working lead. A wearable apparatus for processing ECG data includes at least two flexible electrodes, in which the at least two flexible electrodes are capable of forming different leads based on predetermined configurations, at least two lead wires, and an ECG data collector configured to receive ECG data collected by the at least two flexible electrodes, in which each of the at least two flexible electrodes connects to the ECG data collector via at least one of the at least two lead wires.

A system and method providing outpatient ECG monitoring and safe home based cardiac tele-rehabilitation. The system includes a recordation module for recording ECG signals using at least one lead, a tele-rehabilitation module for home based exercise management for a patient's recovery, the tele-rehabilitation module including a processing module for recognizing erroneous data from the ECG signals and an analysis module for calculating beat-to-beat annotations and determining if an ECG event and/or if a QT interval duration change has occurred. The system can include an exercise module for guiding the patient during an exercise session, a visual display that informs the patient to start and/or to stop the tele-rehabilitation exercise, a visual display and/or audible signal that informs the patient of an incoming or a missed tele-rehabilitation exercise session, and/or a communication module for transmitting/receiving data between the a cardiac tele-rehabilitation module and a physician/monitoring center.

In some examples, controlling delivery of CRT includes delivering ventricular pacing according to a sequence of different values of at least one of A-V delay or V-V delay, and acquiring one or more electrograms from respective vectors. For each of the different values of the at least one of A-V delay or V-V delay, at least one of a QRS amplitude or a QRS area may be determined based on the one or more electrograms, and a target change in QRS amplitude or QRS area between adjacent ones of the values of the at least one of A-V delay or V-V delay of the sequence may be identified. In response to the identification of the target change, the implantable medical device may deliver the ventricular pacing at a value of the at least one of A-V delay or V-V delay determined based on the identification to provide CRT.

A system for cardiac monitoring and therapy includes a mother device configured to receive signals indicative of cardiac electrical activity in a patient's heart. The mother device includes a mother wireless communications module configured to transmit and receive information to d and from the mother device. The system also includes a satellite device configured to receive the signals indicative of the cardiac electrical activity in the patient's heart from a remote location relative to the mother device and includes a satellite wireless communications module configured to transmit from and receive communications sent to the satellite device to at least communicate with the mother wireless communications module. The system also includes a processor configured to receive the signals indicative of the cardiac electrical activity in the heart received by the mother device and the satellite device and, based thereon, control delivery of electrical therapy to the patient's heart.

Acute myocardial infarction (AMI) is diagnosed if: (1) the ECG traces satisfy an ST Elevation Myocardial Infarction (STEMI) criterion and the ECG traces do not indicate the subject has a confounding cardiac condition, or (2) the ECG traces satisfy the STEMI criterion and the ECG traces also indicate the subject has the confounding cardiac condition and a three-dimensional vector cardiograph (3D-VCG) signal generated from the ECG traces includes an ST vector in the ST segment of the 3D-VCG signal and a terminal QRS vector of maximum magnitude in a terminal portion of the QRS complex of the 3D-VCG signal for which the angle between the ST vector and the terminal QRS vector is less than a threshold angle, e.g. in the range [130°, 170°] inclusive. The confounding cardiac condition may be bundle branch block (BBB), left ventricular hypertrophy (LVH), or interventricular conduction delay (IVCD).

The present disclosure provides a system and method of determining a risk score for triage. In particular, a system is provided for providing an assessment of risk of a cardiac event for a patient, for example an incoming patient to a hospital emergency department complaining of chest pain. In the disclosure, the system includes an input device for measuring physiological data based vital signs parameter of the patient, a twelve-lead electrocardiogram (ECG) device for establishing an ECG obtained from results of the electrocardiography procedure, and determining an ECG parameter and a heart rate variability (HRV) parameter therefrom. An ensemble-based scoring system is further provided, establishing weighted classifier based on past patient data and where the vital signs parameter, the ECG parameter and the HRV parameter are compared to corresponding weighted classifiers to determine a risk score. A corresponding method to determine a risk score for triage is also provided.

An apparatus and method is provided that identifies the presence or absence of a P-wave within a set of ECG data. A computation processor identifies the R-wave and then analyses a section of the waveform within a predetermined time window preceding the detected R-wave peak. The waveform within the window is analysed to identify a candidate P-wave, and in response to identifying the candidate P-wave a first and second feature associated therewith is measured. A composite feature value is calculated from the first and second measures, and compared to a classification threshold value. In an exemplary embodiment, the first feature represents a height between a highest peak of the candidate P-wave and a trough of the Q-wave, and the second feature represents a time between the peak of the candidate P-wave and a peak of the R-wave.

One embodiment provides a system for determination and utilization of cardiac electrical asynchrony data. The system includes an analysis circuitry including a processor and a memory, the analysis circuitry configured to: obtain a plurality of sets of cardiac signals collected in at least two locations of a heart of a patient, the signals comprising at least one of surface electrocardiography signals and pseudo-surface ECG signals; detect one or more QRS complexes for each of the sets based on the cardiac signals for that set; obtain one or more cross-correlation signals, each of the cross-correlation signals being between at least two of the signal sets and being obtained using the detected QRS complexes from the signal sets; and calculate one or more asynchrony indices using one or more of the cross-correlation signals, each of the asynchrony indices being indicative of a level of asynchrony between the at least two locations.

An electrocardiogram (ECG) signal processing system is provided. The ECG signal processing system comprises an analog-to-digital converter (ADC) configured to convert an input analog ECG signal into a digital ECG signal, and a digital signal processing engine (DSPE) coupled to the ADC to receive the digital ECG signal. The DSPE is configured to decompose and reconstruct the digital ECG signal. A dynamic system clock source is coupled to the ADC and the DSPE for dynamic signal sampling, the dynamic system clock source clocking the ADC and the DSPE at a first frequency f1 to detect one or more first parameters of the input analog ECG signal and at a second frequency f2 to detect one or more second parameters of the input analog ECG signal.

An adherent device to monitor a patient for an extended period comprises a breathable tape. The breathable tape comprises a porous material with an adhesive coating to adhere the breathable tape to a skin of the patient. At least one electrode is affixed to the breathable tape and capable of electrically coupling to a skin of the patient. A printed circuit board is connected to the breathable tape to support the printed circuit board with the breathable tape when the tape is adhered to the patient. Electronic components electrically are connected to the printed circuit board and coupled to the at least one electrode to measure physiologic signals of the patient. A breathable cover and/or an electronics housing is disposed over the circuit board and electronic components and connected to at least one of the electronics components, the printed circuit board or the breathable tape.